Healthy Skepticism Library item: 1209
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Giaquinta D.
The changing timetable for the evaluation of new products for formulary consideration.
Manag Care Interface 2003 Feb; 16:(2):24-5,
Abstract:
The time for drug manufacturers to educate MCOs about new drugs is not a month before obtaining Food and Drug Administration approval. Today, as Dr. Giaquinta explains, it is imperative that pharmaceutical companies present information about their pipeline products three to five years before drug launch.
Keywords:
Documentation
Drug Approval
Drug Evaluation*
Drug Industry/standards*
Formularies*
Humans
Managed Care Programs*
Time
United States
